Pharmacokinetic Study of SYP-0704A and Taxotere to Treat Patient With Advanced Solid Cancer
NCT01336582 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2012-12-21
Summary
Primary Objective: Evaluation of the pharmacokinetic equivalence of two Docetaxel formulations in terms of AUC and Cmax.
Conditions
Interventions
- DRUG
-
taxotere
70 mg/m2 for age of ≥ 65
Sponsors & Collaborators
-
Samyang Biopharmaceuticals Corporation
lead INDUSTRY
Principal Investigators
-
Shin je gook, doctor · Inje Pusan Paik university hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2012-04-30
- Completion
- 2012-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
Pharmacokinetics Study of Liposomal Paclitaxel in Humans
NCT00606515 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Anti-tumor Activity of SYHA1801 Monotherapy in Patients With Advanced Solid Tumors
NCT04309968 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3558 Tablets
NCT04408079 ·Status: UNKNOWN ·Phase: PHASE1
-
The Comparison of the Pharmacokinetics of Albumin-bound Docetaxel and Taxotere
NCT04811118 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics
NCT04523285 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors
NCT04128085 ·Status: UNKNOWN ·Phase: PHASE1
-
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors
NCT01907685 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets
NCT04481607 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of ADRX-0706 in Select Advanced Solid Tumors
NCT06036121 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients
NCT06139536 ·Status: RECRUITING ·Phase: PHASE1
-
A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors
NCT06907628 ·Status: RECRUITING ·Phase: PHASE1
-
A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)
NCT04009681 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors
NCT06639256 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Troxatyl™ Administered by Continuous Infusion to Subjects With Solid Tumors
NCT00104286 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors
NCT03700294 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors
NCT01867879 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid Tumors
NCT06775236 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
NCT02301104 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TJ107 in Chinese Patients With Advanced Solid Tumors
NCT04001075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies
NCT03370302 ·Status: TERMINATED ·Phase: PHASE1
-
A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
NCT06815575 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics
NCT03019276 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer
NCT06163391 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of SHR-3821 Injection in Subjects With Advanced Solid Tumors
NCT06618651 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors
NCT01567163 ·Status: COMPLETED ·Phase: PHASE2